Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 547,950 | 507,590 | 547,180 | 634,490 | 753,110 |
| Marketable Securities | 308,100 | 256,060 | 184,180 | 77,970 | 48,750 |
| Receivables | 119,020 | 113,710 | 95,100 | 97,180 | 102,910 |
| Inventories | 98,040 | 95,950 | 85,530 | 0 | 86,130 |
| Other current assets | 64,290 | 58,700 | 56,460 | 145,440 | 58,810 |
| TOTAL | $1,137,400 | $1,032,010 | $968,450 | $955,080 | $1,049,710 |
| Non-Current Assets | |||||
| Investments And Advances | 165,840 | 223,740 | 338,480 | 425,790 | 320,140 |
| Other Non-Current Assets | 1,207,850 | 1,236,770 | 1,171,860 | 1,172,190 | 1,189,020 |
| TOTAL | $1,373,690 | $1,460,510 | $1,510,340 | $1,597,980 | $1,509,160 |
| Total Assets | $2,660,100 | $2,639,050 | $2,614,960 | $2,683,670 | $2,691,280 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 160 | 6,420 | 2,450 | 2,240 | 290 |
| Accounts payable and accrued liabilities | 19,340 | 19,190 | 20,430 | 20,810 | 22,150 |
| Accrued Expenses | 88,810 | 84,610 | 87,590 | 73,200 | 76,990 |
| TOTAL | $127,550 | $151,620 | $140,950 | $135,710 | $139,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,570 | 24,720 | 2,030 | 12,050 | 14,480 |
| Other Non-Current Liabilities | 699,120 | 698,380 | 697,990 | 691,940 | 691,620 |
| TOTAL | $837,070 | $825,510 | $831,380 | $834,900 | $843,330 |
| Total Liabilities | $964,640 | $977,160 | $972,350 | $970,630 | $982,550 |
| Shareholders' Equity | |||||
| Common Shares | 530 | 530 | 530 | 530 | 530 |
| Retained earnings | -110,780 | -127,710 | -144,620 | -154,770 | -169,700 |
| Other shareholders' equity | 27,800 | 16,280 | 14,910 | 10,120 | 9,190 |
| TOTAL | $1,695,460 | $1,661,890 | $1,642,610 | $1,713,040 | $1,708,730 |
| Total Liabilities And Equity | $2,660,100 | $2,639,050 | $2,614,960 | $2,683,670 | $2,691,280 |